Not yet recruiting
Pembrolizumab in Combination with Flutamide Treatment for Recurrence / Metastasis HNSCC
NCT06694350
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
Not specified